Wolfgang Kandioller

26PUBLICATIONS
79CO-AUTHORS
Biomolecular modelling and designTransition metal chemistryMain group metal chemistryMolecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 30, 2026
Leveraging Morphological Profiling for Mechanistic Elucidation of Metal-Based Anticancer Compounds.

|Jan 20, 2026
Naphthoquinone-derived tridentate Ru(II) and Os(II) organometallics with exceptional cytotoxicity: synthesis, characterization, stability in aqueous solution and biological in vitro evaluation.

Alexander Rosner, Heiko Geisler, Michaela Hejl

|Sep 29, 2025
Exploring the Anticancer Properties of 4-Phenylthiazole-Based Ru(II) and Os(II) Metallacycles Featuring 1-Methylimidazole as N-Donor Functionality.

Paul Getreuer, Theresa Mendrina, Steven van Terwingen

|Aug 06, 2025
Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.

Alexander Rosner, Lukas Skos, Theresa Mendrina

|Mar 28, 2024
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability.

Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder

|Mar 12, 2024
Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103.

B Happl, T Balber, P Heffeter

Pageof 5

Frequent Collaborators

14 joint publications

Michael A Jakupec

9 joint publications

Bernhard K Keppler

6 joint publications

Petra Heffeter

6 joint publications

Walter Berger